Works matching IS 01435221 AND DT 2020 AND VI 134 AND IP 23


Results: 12
    1
    2
    3
    4
    5
    6
    7
    8
    9

    SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: Tubular effects of SGLT2 inhibition in Type 2 diabetes.

    Published in:
    Clinical Science, 2020, v. 134, n. 23, p. 3107, doi. 10.1042/CS20201274
    By:
    • van Bommel, Erik J. M.;
    • Geurts, Frank;
    • Muskiet, Marcel H. A.;
    • Post, Adrian;
    • Bakker, Stephan J. L.;
    • Danser, A. H. Jan;
    • Touw, Daan J.;
    • van Berkel, Miranda;
    • Kramer, Mark H. H.;
    • Nieuwdorp, Max;
    • Ferrannini, Ele;
    • Joles, Jaap A.;
    • Hoorn, Ewout J.;
    • van Raalte, Danië l H.
    Publication type:
    Article
    10

    ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats.

    Published in:
    Clinical Science, 2020, v. 134, n. 23, p. 3093, doi. 10.1042/CS20201022
    By:
    • Silva de Almeida, Tatiane Cristine;
    • Lanza, Katharina;
    • da Silva Filha, Roberta;
    • Campos, Leda Maria de Castro C.;
    • Fonseca, Esdras G.;
    • Chagas, Mariana W.;
    • Pessoa Rocha, Natalia;
    • Augusto de Sá, Marcos;
    • Ribeiro Vieira, Maria Aparecida;
    • Vidigal Caliari, Marcelo;
    • Kangussu, Lucas M.;
    • José Ferreira, Anderson;
    • Simões e Silva, Ana Cristina
    Publication type:
    Article
    11
    12

    ACE2 in the renin-angiotensin system.

    Published in:
    2020
    By:
    • Verano-Braga, Thiago;
    • Valle Martins, Ana Luiza;
    • Motta-Santos, Daisy;
    • José Campagnole-Santos, Maria;
    • Souza Santos, Robson Augusto
    Publication type:
    Literature Review